Cymarin
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C30H44O9 |
Molar mass | 548.665 g/mol |
WikiDoc Resources for Cymarin |
Articles |
---|
Most recent articles on Cymarin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cymarin at Clinical Trials.gov Clinical Trials on Cymarin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cymarin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Cymarin Risk calculators and risk factors for Cymarin
|
Healthcare Provider Resources |
Causes & Risk Factors for Cymarin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cymarin (or cymarine) is a cardiac glycoside. Apocynum cannabinum used as a source of fiber by Native Americans and Apocynum venetum used as a herbal tea in China both contain cymarin.[1] Cymarin is a cardiac glycoside and an anti-arrhythmia and cardiotonic agent.[2]
References
- ↑ Edible and Medicinal plants of the West, Gregory L. Tilford, ISBN 0-87842-359-1
- ↑ http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=539061#x94
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cardiac glycosides
- Cardiovascular Drugs
- Drug